Hospital Pharmacy Europe
Hospitalpharmacyeurope.com is a complimentary platform that supports the Hospital Pharmacy Europe (HPE) journal. Users can easily access the complete content of each issue online, allowing pharmacists to quickly find and read well-written articles on subjects that matter to them with just a click.
Outlet metrics
Global
#2212696
India
#256716
Health/Pharmacy
#253
Articles
-
1 week ago |
hospitalpharmacyeurope.com | Ravijyot Saggu |Helena Beer
The National Child Mortality Database report on child deaths related to asthma and allergies was released in December 2024, providing sobering insights. Pharmacist Ravijyot Saggu offers an expert summary, emphasising key points from the thematic report and discussing necessary future actions.
-
2 weeks ago |
hospitalpharmacyeurope.com | Helena Beer
Non-adherence can negatively impact medication treatment strategies, particularly among oncology patients, driving up treatment costs while potentially worsening clinical outcomes. Although oral oncolytics offer convenience, they arguably require greater patient engagement in remembering to take their treatment, often resulting in lower adherence compared to infused therapies. Chronic lymphocytic leukaemia (CLL) is increasingly managed with long-duration, targeted oral treatments.
-
2 weeks ago |
hospitalpharmacyeurope.com | Helena Beer
A digital self-assessment tool designed to help hospital pharmacy teams take practical action to support sustainability and reduce the environmental impact of pharmacy services, pharmaceutical care and medicines, while supporting patient care, has been launched by the Royal Pharmaceutical Society (RPS).
-
2 weeks ago |
hospitalpharmacyeurope.com | Helena Beer
Theranostics integrates diagnostic and therapeutic radiopharmaceuticals targeting the same molecular structures – delivering a ‘one-two punch’ for personalised cancer care. In his latest commentary, Professor Alain Astier discusses how the radionuclide 177Lu and 177Lu-based radioligands have gained traction in treating various conditions, including neuroendocrine tumours and metastatic prostate cancer.
-
3 weeks ago |
hospitalpharmacyeurope.com | Gerry Hughes |Helena Beer
A recent study assessing the carbon footprint of a hospital pharmacy’s cytotoxic drug production unit and its main sources of greenhouse gas (GHG) emissions has revealed potential areas for improvement to reduce its global warming impact. Global health authorities forecast an additional 250,000 annual deaths from climate change between 2030 and 2050. Rising temperatures and extreme weather events are driving higher rates of food- and water-borne illnesses, amongst other conditions.
Hospital Pharmacy Europe journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →